positive skin cancer drug data boosts roche
roche's new cancer drug vismodegib could help patients with a potentially fatal skin cancer type, positive mid-stage trial results showed, going some way to lift confidence in the drugmaker after a rough 2010.
http://feeds.reuters.com/~r/reuters/healthnews/~3/cs9_nn-w-4e/us-roche-idustre72k3cq20110321
29214
21 Mar 2011 15:03:47
reuters
health